December 16, 2024

Smoke Travels 2,100 Miles, Hits Heart Health

A case-only study published in JAMA Network Open reveals a significant increase in cardiopulmonary clinical encounters in Maryland during June 2023, associated with remote wildfire smoke exposure, extending beyond the immediate wildfire vicinity.

Conexiant

December 13, 2024

New Myocarditis Guidelines Define Disease Stages

ACC consensus pathway introduces stages A through D for myocarditis classification, paralleling the established heart failure staging system cardiologists use daily.

Conexiant

December 13, 2024

Air Pollution Tied to Blood Clots in Veins

In a 17-year study of over 6,600 adults, researchers found that for every 3.6 µg/m3 increase in PM2.5 exposure, VTE risk increased by 39%, with even stronger associations observed in the first decade of follow-up.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant

December 12, 2024

Comparing Ticagrelor and Prasugrel in ACS

In a 17,642-patient cohort study validating ISAR-REACT5's findings, prasugrel showed particular benefit in STEMI patients, with a striking 38% relative risk reduction in adverse events compared to ticagrelor, while maintaining similar bleeding risks.

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.

Conexiant

December 10, 2024

ASCVD Risk Elevated in Cutaneous Lupus

Recent study in JAMA Dermatology shows patients with cutaneous lupus erythematosus have a 72% higher risk of developing atherosclerotic cardiovascular disease, emphasizing the need for targeted screening and management.

Conexiant

December 09, 2024

Breast Calcifications Linked to CVD Risk

A recent study found that women with breast arterial calcification detected on mammograms face an approximately 50% increase in risk of cardiovascular events and mortality. The findings suggest that BAC may serve as an early marker of cardiovascular disease risk.

Conexiant

December 09, 2024

CLEAR Trial: Evaluating Spironolactone in Post-MI Care

A recent study evaluated the routine use of spironolactone in patients with myocardial infarction to assess its effect on cardiovascular outcomes.

Conexiant